Hydroxychloroquine appears to increase risk of mortality when used to treat COVID-19The largest study on the drug to date found that not only is there no benefit in treating COVID-19, but also a very consistent risk of harm COVID-19 and post-infection immunity: what’s known and unknownResearch on post-infection immunity boosted by Health Canada’s approval of first serological test for IgG antibodies against SARS-CoV-2 Pediatric multisystem inflammatory syndrome possibly linked to COVID-19 UK and US issue health alerts regarding Kawasaki disease shock syndrome-like illness in children and teenagers Researchers ponder whether COVID-19 could be sexually transmitted SARS-CoV-2 virus found in semen of six of 38 men hospitalized with COVID-19 Chicago researchers question the use of delayed antibiotic prescriptions Delayed antibiotic prescriptions do not improve patient outcomes and unnecessarily expose patients to harm Face shields might be more useful than face masks for protecting the public from COVID-19 Iowa researchers outline potential advantages of using face shields as an alternative to face masks in the community Could remdesivir be a game changer for COVID patients? Experts say wait for data One U.S. study found recovery in patients using the drug was shortened by 31%—11 days on average versus 15 days for those just given usual care New series of videos on COVID-19: What Pharmacists Know Now The BC Branch of the Canadian Society of Hospital Pharmacists releases educational videos on COVID-19 Canadian interim guidelines for managing patients with moderate to severe COVID-19 Provide advice on timely, effective and safe supportive management of adults and children with suspected or confirmed COVID-19 Gilead seeks Health Canada approval for HIV PrEP indication for Descovy Submission based on data from the DISCOVER trial, which compared Descovy to Truvada First Previous 59 60 61 62 63 Next Last
